Gene · 7399
Papers2,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gene Therapy for Inherited Retinal Diseases: From Laboratory Bench to Patient Bedside and Beyond. | Ophthalmol Ther | 2024 | 38113023 | PubTator, text mining | PubMed |
| Multi-omics approach for identifying CNV-associated lncRNA signatures with prognostic value in prostate cancer. | Noncoding RNA Res | 2024 | 38075203 | PubTator, text mining | PubMed |
| Genomic landscape of patients with germline RUNX1 variants and familial platelet disorder with myeloid malignancy. | Blood Adv | 2024 | 38019014 | PubTator, text mining | PubMed |
| The p.C759F Variant in USH2A Is a Pathogenic Mutation: Systematic Literature Review and Meta-Analysis of 667 Genotypes. | Ophthalmic Res | 2024 | 38016437 | PubTator, text mining | PubMed |
| Recombinant duck enteritis virus bearing the hemagglutinin genes of H5 and H7 influenza viruses is an ideal multivalent live vaccine in ducks. | Emerg Microbes Infect | 2024 | 37966272 | PubTator, text mining | PubMed |
| Whole genome sequencing for inherited retinal diseases in the Korean National Project of Bio Big Data. | Graefes Arch Clin Exp Ophthalmol | 2024 | 37947821 | PubTator, text mining | PubMed |
| Co-mutation of TP53 and TTN is Correlated with the Efficacy of Immunotherapy in Lung Squamous Cell Carcinoma. | Comb Chem High Throughput Screen | 2024 | 37904553 | PubTator, text mining | PubMed |
| Adaptive optics imaging in inherited retinal diseases: A scoping review of the clinical literature. | Surv Ophthalmol | 2024 | 37778667 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing Analysis of Idiopathic Hypogonadotropic Hypogonadism: Comparison of Varicocele and Nonobstructive Azoospermia. | Reprod Sci | 2024 | 37679557 | PubTator, text mining | PubMed |
| Molecular genetic diagnostics for inherited retinal dystrophies in the clinical setting. | Can J Ophthalmol | 2024 | 37678418 | PubTator, text mining | PubMed |
| Full-field stimulus threshold testing: a scoping review of current practice. | Eye (Lond) | 2024 | 37443335 | PubTator, text mining | PubMed |
| Novel cis compound heterozygous variants in MYO6 causes early onset of non-syndromic hearing loss in a Chinese family. | Front Genet | 2023 | 38274113 | PubTator, text mining | PubMed |
| Cell-Free Genic Extrachromosomal Circular DNA Profiles of DNase Knockouts Associated with Systemic Lupus Erythematosus and Relation with Common Fragile Sites. | Biomedicines | 2023 | 38255187 | PubTator, text mining | PubMed |
| The Potential and Application of iPSCs in Gene and Cell Therapy for Retinopathies and Optic Neuropathies. | Acta Naturae | 2023 | 38234607 | PubTator, text mining | PubMed |
| A ten long noncoding RNA-based prognostic risk model construction and mechanism study in the basal-like immune-suppressed subtype of triple-negative breast cancer. | Transl Cancer Res | 2023 | 38193005 | PubTator, text mining | PubMed |
| Identification of a novel compound heterozygous pathogenic variant in MYO7A causing Usher syndrome type IB in a Chinese patient: a case report. | J Int Med Res | 2023 | 38141656 | PubTator, text mining | PubMed |
| Pathogenic Variants in USH1G/SANS Alter Protein Interaction with Pre-RNA Processing Factors PRPF6 and PRPF31 of the Spliceosome. | Int J Mol Sci | 2023 | 38139438 | PubTator, text mining | PubMed |
| Recent Therapeutic Progress and Future Perspectives for the Treatment of Hearing Loss. | Biomedicines | 2023 | 38137568 | PubTator, text mining | PubMed |
| Deep Learning-Assisted Measurements of Photoreceptor Ellipsoid Zone Area and Outer Segment Volume as Biomarkers for Retinitis Pigmentosa. | Bioengineering (Basel) | 2023 | 38135984 | PubTator, text mining | PubMed |
| Which Came First? When Usher Syndrome Type 1 Couples with Neuropsychiatric Disorders. | Audiol Res | 2023 | 38131811 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7399/papers?page=12